Dihydroergotamine
| Use attributes for filter ! | |
| Molar mass | 583. 678 g/mol |
|---|---|
| Trade name | D. H. E. 45, Migranal, others |
| Other names | (5'α)-9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-ergotaman-3',6',18-trione |
| Elimination half-life | 9 hours |
| Pronunciation | /daɪˌhaɪdroʊ. ɜːrˈɡɒtəmiːn/ dy-HY-droh-ur-GOT-ə-meen |
| License data | US |
| FDA | |
| Music groups | Ergotamine |
| Sumatriptan | |
| Migraine | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2173472 |
About Dihydroergotamine
Dihydroergotamine is an ergot alkaloid used to treat migraines. It is a derivative of ergotamine. It is administered as a nasal spray or injection and has an efficacy similar to that of sumatriptan. Nausea is a common side effect.